Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level

NCT03488706 · clinicaltrials.gov ↗
UNKNOWN
Status
500
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

CellMaxLife